Korean Market
EXCH
Hanall Biopharma
★
Conditional License Agreement for mRNA-based ERA Platform… Total $239M
 05/20/2026, 05:54 PM
EXCH
Hanall Biopharma
★★★★
Q1 2026 Operating Profit Swings to Black, Revenue Up 10.7%
 05/16/2026, 07:51 PM
MATR
Hanall Biopharma
★
Disposal of 66,004 Treasury Shares (0.13%) for Stock Option Exercise
 05/16/2026, 07:51 PM
PERI
Hanall Biopharma
★★
HanAll BioPharma Q1 Turns to Profit, Pipeline Advances; Harbour Arbitration Risk Remains
 05/15/2026, 02:54 PM
OTHR
Hanall Biopharma
★
Hanall Biopharma Completes Disposal of 66,004 Treasury Shares
 05/06/2026, 04:50 PM
OWNR
Hanall Biopharma
★
Filing of Report on Ownership of Specific Securities by Executives and Major Shareholders (No Changes)
 05/06/2026, 04:44 PM
OWNR
Hanall Biopharma
★
No Material Changes in Executive/Major Shareholder Ownership Report
 05/06/2026, 04:40 PM
OWNR
Hanall Biopharma
★
No Change in Executive/Major Shareholder Holdings
 05/06/2026, 04:37 PM
EXCH
Hanall Biopharma
★
HanAll Biopharma Major Shareholder Ownership Increases 0.04%
 05/06/2026, 04:30 PM